Live tracker · Updated September 17, 2026

FDA approved
peptides.

Q: Which peptides are FDA approved?

In the wellness space: semaglutide, tirzepatide and liraglutide for weight and diabetes, tesamorelin for HIV-associated visceral fat, bremelanotide for low desire in premenopausal women, setmelanotide for rare genetic obesity, and afamelanotide for a rare light-sensitivity disease. Insulins and many hospital peptides are approved too.

Q: Is BPC-157 FDA approved?

No. BPC-157 is not approved for any use and sits on the FDA compounding risk list. TB-500, ipamorelin, CJC-1295, MOTS-c and most research peptides are not approved either.

Q: Is sermorelin FDA approved?

Sermorelin was once approved as Geref and was discontinued for commercial reasons, not safety. Today it is available as a compounded prescription, which is lawful but not an FDA-approved product.

The actual list — which peptide drugs carry real approvals, which are lawful compounds, and which popular names have no approval at all.

Live page — additions and status changes are logged below with dates

Approved and relevant

Peptide	Brand names	Approved for
Semaglutide	Ozempic, Wegovy, Rybelsus	Type 2 diabetes; chronic weight management
Tirzepatide	Mounjaro, Zepbound	Type 2 diabetes; chronic weight management; sleep apnea with obesity
Liraglutide	Victoza, Saxenda	Type 2 diabetes; weight management, now with generics
Tesamorelin	Egrifta	Visceral fat reduction in HIV-associated lipodystrophy
Bremelanotide	Vyleesi	Low sexual desire in premenopausal women
Setmelanotide	Imcivree	Rare genetic obesity syndromes
Afamelanotide	Scenesse	Erythropoietic protoporphyria, hospital administered
Teriparatide	Forteo and generics	Osteoporosis

Lawful without approval

Compounded prescriptions occupy the middle ground: sermorelin, ipamorelin blends, NAD+ and others can be dispensed by licensed pharmacies against a physician order. Lawful path, real oversight — but not FDA-approved products, and quality rests on the pharmacy.

Not approved at all

BPC-157, TB-500, CJC-1295, MOTS-c, Semax, Selank, DSIP, KPV, epitalon, melanotan II and retatrutide have no approval anywhere in the US system. BPC-157 additionally sits on the FDA list of compounding substances with significant safety risk. Sold online only as research chemicals.

Find the approved option for your goal

What changed

September 17, 2026 — tracker launched

List compiled at launch: eight approved peptide drugs relevant to wellness, the compounded middle tier, and the no-approval tier. Retatrutide remains investigational — its own tracker follows the approval.

Questions people ask

Which peptides are FDA approved?

The table above is the current list that matters in wellness. Hospital peptides and insulins extend it far beyond this page's scope.

Is BPC-157 FDA approved?

No, for no use — and the FDA flagged it for compounding risk. The BPC-157 guide covers what that means in practice.

Is sermorelin FDA approved?

It was, as Geref, and left the market commercially. Today it is a lawful compounded prescription rather than an approved product.

Sources: FDA Drugs database · FDA compounding risk list

FDA approved
peptides.

Approved and relevant

Lawful without approval

Not approved at all

What changed

Questions people ask

Related reading

Retatrutide tracker

The honest top list

Get prescribed

FDA approvedpeptides.

Approved and relevant

Lawful without approval

Not approved at all

What changed

Questions people ask

Related reading

Retatrutide tracker

The honest top list

Get prescribed

FDA approved
peptides.